Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CERTOLIZUMAB PEGOL Cause Rheumatoid arthritis? 17,782 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 17,782 reports of Rheumatoid arthritis have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 17.9% of all adverse event reports for CERTOLIZUMAB PEGOL.

17,782
Reports of Rheumatoid arthritis with CERTOLIZUMAB PEGOL
17.9%
of all CERTOLIZUMAB PEGOL reports
1,735
Deaths
3,510
Hospitalizations

How Dangerous Is Rheumatoid arthritis From CERTOLIZUMAB PEGOL?

Of the 17,782 reports, 1,735 (9.8%) resulted in death, 3,510 (19.7%) required hospitalization, and 2,076 (11.7%) were considered life-threatening.

Is Rheumatoid arthritis Listed in the Official Label?

Yes, Rheumatoid arthritis is listed as a known adverse reaction in the official FDA drug label for CERTOLIZUMAB PEGOL.

What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?

Drug ineffective (23,838) Pain (13,929) Fatigue (11,438) Off label use (10,281) Rash (9,663) Alopecia (9,111) Maternal exposure during pregnancy (9,013) Arthralgia (8,993) Abdominal discomfort (8,615) Joint swelling (8,607)

What Other Drugs Cause Rheumatoid arthritis?

ETANERCEPT (33,166) ADALIMUMAB (29,817) METHOTREXATE (29,254) ABATACEPT (21,898) LEFLUNOMIDE (20,886) TOCILIZUMAB (20,652) HYDROXYCHLOROQUINE (20,110) RITUXIMAB (19,850) INFLIXIMAB (16,251) SULFASALAZINE (15,136)

Which CERTOLIZUMAB PEGOL Alternatives Have Lower Rheumatoid arthritis Risk?

CERTOLIZUMAB PEGOL vs CERTOPARIN CERTOLIZUMAB PEGOL vs CETIRIZINE CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE CERTOLIZUMAB PEGOL vs CETRIMIDE CERTOLIZUMAB PEGOL vs CETRORELIX

Related Pages

CERTOLIZUMAB PEGOL Full Profile All Rheumatoid arthritis Reports All Drugs Causing Rheumatoid arthritis CERTOLIZUMAB PEGOL Demographics